# Comparison of Cadazolid Versus Vancomycin in Children With Clostridium Difficile-associated Diarrhea (CDAD)

> **NCT03105479** · PHASE2,PHASE3 · TERMINATED · sponsor: **Actelion** · enrollment: 1 (actual)

## Conditions studied

- Clostridium Difficile Infection

## Interventions

- **DRUG:** Cadazolid
- **DRUG:** Vancomycin capsule
- **DRUG:** Vancomycin solution

## Key facts

- **NCT ID:** NCT03105479
- **Lead sponsor:** Actelion
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-04-14
- **Primary completion:** 2018-04-17
- **Final completion:** 2018-04-17
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Study suspended in October 2017 and terminated April 17, 2018 after decision to discontinue the study drug development
- **Last updated:** 2025-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03105479

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03105479, "Comparison of Cadazolid Versus Vancomycin in Children With Clostridium Difficile-associated Diarrhea (CDAD)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03105479. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*